Requiring the Maryland Medical Assistance Program, beginning January 1, 2021, to provide services for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome under certain circumstances; requiring carriers to provide coverage for certain diagnosis, evaluation, and treatment of pediatric autoimmune neuropsychiatric disorders; applying the Act to all policies, contracts and health benefit plans issued, delivered, or renewed in the State on or after January 1, 2021; etc.
Bill File Type: Regular
Effective Date(s): January 1, 2021
( 15-855 )
Last Updated: 2/7/2020 8:45 AM